Teva, Purdue Put OxyContin Litigation Behind Them

Law360, New York (October 16, 2006, 12:00 AM EDT) -- A federal judge has signed off on the settlement agreement over a generic version of painkiller OxyContin between generic drug maker Teva Pharmaceuticals Industries Ltd. and Purdue Pharma LP, bringing pending litigation to an end.

Israel-based Teva was given a full release from the litigation and Stamford, Conn.-based pharmaceutical Purdue will not seek damages for past infringement, the companies said.

Under the terms of the settlement agreement, Teva will cease selling oxycodone products at an unspecified future date. Teva said that it anticipates sales of its...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.